• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 5, 2024

    3/5/24 5:00:02 AM ET
    $AEVA
    $AGS
    $AGTI
    $ALNT
    Auto Parts:O.E.M.
    Consumer Discretionary
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Get the next $AEVA alert in real time by email

    Companies Reporting Before The Bell

    • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.

    • Target (NYSE:TGT) is estimated to report quarterly earnings at $2.22 per share on revenue of $29.33 billion.

    • 2seventy bio (NASDAQ:TSVT) is expected to report quarterly loss at $0.99 per share on revenue of $14.71 million.

    • CLPS (NASDAQ:CLPS) is expected to report earnings for its first quarter.

    • Seres Therapeutics (NASDAQ:MCRB) is projected to report quarterly loss at $0.50 per share on revenue of $350 thousand.

    • Vivid Seats (NASDAQ:SEAT) is expected to report quarterly earnings at $0.06 per share on revenue of $183.67 million.

    • Nuwellis (NASDAQ:NUWE) is projected to report quarterly loss at $1.39 per share on revenue of $2.55 million.

    • Consolidated Comms Hldgs (NASDAQ:CNSL) is likely to report quarterly loss at $0.36 per share on revenue of $276.94 million.

    • CECO Environmental (NASDAQ:CECO) is likely to report quarterly earnings at $0.24 per share on revenue of $146.61 million.

    • 908 Devices (NASDAQ:MASS) is expected to report quarterly loss at $0.26 per share on revenue of $14.16 million.

    • Neuronetics (NASDAQ:STIM) is projected to report quarterly loss at $0.26 per share on revenue of $19.85 million.

    • Broadwind (NASDAQ:BWEN) is expected to report quarterly earnings at $0.00 per share on revenue of $50.15 million.

    • Global Business Travel (NYSE:GBTG) is projected to report quarterly loss at $0.03 per share on revenue of $541.17 million.

    • Riskified (NYSE:RSKD) is likely to report quarterly earnings at $0.03 per share on revenue of $84.02 million.

    • Angel Oak Mortgage REIT (NYSE:AOMR) is expected to report quarterly earnings at $0.18 per share on revenue of $9.00 million.

    • L.B. Foster (NASDAQ:FSTR) is expected to report quarterly earnings at $0.01 per share on revenue of $129.35 million.

    • Rand Capital (NASDAQ:RAND) is expected to report earnings for its fourth quarter.

    • Dave (NASDAQ:DAVE) is likely to report earnings for its fourth quarter.

    • Sophia Genetics (NASDAQ:SOPH) is projected to report quarterly loss at $0.26 per share on revenue of $17.33 million.

    • First Watch Restaurant Gr (NASDAQ:FWRG) is expected to report quarterly earnings at $0.04 per share on revenue of $237.53 million.

    • Compugen (NASDAQ:CGEN) is likely to report quarterly earnings at $0.22 per share on revenue of $20.00 million.

    • SmartRent (NYSE:SMRT) is likely to report quarterly loss at $0.01 per share on revenue of $59.49 million.

    • Ferguson (NYSE:FERG) is estimated to report quarterly earnings at $1.85 per share on revenue of $6.77 billion.

    • Cipher Mining (NASDAQ:CIFR) is estimated to report quarterly loss at $0.04 per share on revenue of $41.78 million.

    • Axogen (NASDAQ:AXGN) is likely to report quarterly loss at $0.10 per share on revenue of $41.65 million.

    • V2X (NYSE:VVX) is expected to report quarterly earnings at $0.33 per share on revenue of $1.01 billion.

    • Wag Group (NASDAQ:PET) is likely to report earnings for its fourth quarter.

    • Myers Indus (NYSE:MYE) is expected to report quarterly earnings at $0.26 per share on revenue of $196.19 million.

    Companies Reporting After The Bell

    • Fabrinet (NYSE:FN) is estimated to report quarterly earnings at $0.80 per share on revenue of $197.70 million.

    • Nordstrom (NYSE:JWN) is estimated to report quarterly earnings at $0.88 per share on revenue of $4.39 billion.

    • BlackRock Cap Inv (NASDAQ:BKCC) is likely to report quarterly earnings at $0.12 per share on revenue of $20.32 million.

    • Presto Automation (NASDAQ:PRST) is likely to report earnings for its fourth quarter.

    • Kingsway Financial Servs (NYSE:KFS) is likely to report earnings for its fourth quarter.

    • Emergent BioSolutions (NYSE:EBS) is expected to report quarterly loss at $0.19 per share on revenue of $293.53 million.

    • Cumberland (NASDAQ:CPIX) is likely to report earnings for its fourth quarter.

    • TRACON Pharma (NASDAQ:TCON) is likely to report quarterly loss at $0.08 per share on revenue of $1.00 million.

    • Entravision Comms (NYSE:EVC) is projected to report quarterly earnings at $0.07 per share on revenue of $308.47 million.

    • Bionano Genomics (NASDAQ:BNGO) is projected to report quarterly loss at $0.87 per share on revenue of $10.58 million.

    • Inspirato (NASDAQ:ISPO) is likely to report quarterly loss at $3.66 per share on revenue of $73.50 million.

    • Marinus Pharma (NASDAQ:MRNS) is expected to report quarterly loss at $0.62 per share on revenue of $8.01 million.

    • Allient (NASDAQ:ALNT) is expected to report quarterly earnings at $0.32 per share on revenue of $132.56 million.

    • Bristow Group (NYSE:VTOL) is projected to report quarterly earnings at $0.54 per share on revenue of $329.20 million.

    • Greenlight Capital Re (NASDAQ:GLRE) is estimated to report earnings for its fourth quarter.

    • Rigel Pharmaceuticals (NASDAQ:RIGL) is estimated to report quarterly loss at $0.03 per share on revenue of $34.10 million.

    • Plus Therapeutics (NASDAQ:PSTV) is projected to report quarterly loss at $1.07 per share on revenue of $1.06 million.

    • Socket Mobile (NASDAQ:SCKT) is estimated to report quarterly loss at $0.06 per share on revenue of $4.91 million.

    • Nyxoah (NASDAQ:NYXH) is expected to report quarterly loss at $0.40 per share on revenue of $1.95 million.

    • Park-Ohio Hldgs (NASDAQ:PKOH) is likely to report quarterly earnings at $0.55 per share on revenue of $386.45 million.

    • W&T Offshore (NYSE:WTI) is expected to report quarterly earnings at $0.01 per share on revenue of $138.42 million.

    • Cadre Hldgs (NYSE:CDRE) is projected to report quarterly earnings at $0.18 per share on revenue of $121.79 million.

    • Semler Scientific (NASDAQ:SMLR) is expected to report quarterly earnings at $0.57 per share on revenue of $14.50 million.

    • Agiliti (NYSE:AGTI) is projected to report quarterly earnings at $0.11 per share on revenue of $291.41 million.

    • Nuvei (NASDAQ:NVEI) is projected to report quarterly earnings at $0.45 per share on revenue of $319.51 million.

    • Franco-Nevada (NYSE:FNV) is estimated to report quarterly earnings at $0.84 per share on revenue of $283.00 million.

    • Mayville Engineering (NYSE:MEC) is projected to report quarterly earnings at $0.13 per share on revenue of $152.30 million.

    • Aquestive Therapeutics (NASDAQ:AQST) is likely to report quarterly loss at $0.08 per share on revenue of $11.63 million.

    • Orthofix Medical (NASDAQ:OFIX) is expected to report earnings for its fourth quarter.

    • MeridianLink (NYSE:MLNK) is estimated to report quarterly loss at $0.13 per share on revenue of $74.86 million.

    • Ross Stores (NASDAQ:ROST) is likely to report earnings for its fourth quarter.

    • Cerus (NASDAQ:CERS) is expected to report quarterly loss at $0.02 per share on revenue of $49.27 million.

    • American Public Education (NASDAQ:APEI) is projected to report quarterly earnings at $0.14 per share on revenue of $150.47 million.

    • Cricut (NASDAQ:CRCT) is estimated to report quarterly earnings at $0.05 per share on revenue of $249.68 million.

    • Crexendo (NASDAQ:CXDO) is projected to report quarterly earnings at $0.04 per share on revenue of $13.80 million.

    • Aeva Technologies (NYSE:AEVA) is likely to report quarterly loss at $0.15 per share on revenue of $1.57 million.

    • LSB Industries (NYSE:LXU) is estimated to report quarterly earnings at $0.04 per share on revenue of $127.21 million.

    • PlayAGS (NYSE:AGS) is projected to report quarterly earnings at $0.03 per share on revenue of $92.57 million.

    • Full House Resorts (NASDAQ:FLL) is likely to report quarterly loss at $0.14 per share on revenue of $63.13 million.

    • CrowdStrike Holdings (NASDAQ:CRWD) is expected to report quarterly earnings at $0.82 per share on revenue of $839.04 million.

    • HashiCorp (NASDAQ:HCP) is expected to report quarterly earnings at $0.01 per share on revenue of $149.29 million.

    • Banco BBVA Argentina (NYSE:BBAR) is estimated to report earnings for its fourth quarter.

    • NeuroPace (NASDAQ:NPCE) is expected to report quarterly loss at $0.31 per share on revenue of $17.46 million.

    • Couchbase (NASDAQ:BASE) is projected to report earnings for its fourth quarter.

    • Ooma (NYSE:OOMA) is likely to report quarterly earnings at $0.12 per share on revenue of $61.46 million.

    • ChargePoint Hldgs (NYSE:CHPT) is likely to report quarterly loss at $0.13 per share on revenue of $119.59 million.

    • ODDITY Tech (NASDAQ:ODD) is expected to report earnings for its fourth quarter.

    • NewtekOne (NASDAQ:NEWT) is projected to report quarterly earnings at $0.58 per share on revenue of $63.35 million.

    • Box (NYSE:BOX) is expected to report quarterly earnings at $0.38 per share on revenue of $262.95 million.

    • Weyco Group (NASDAQ:WEYS) is projected to report earnings for its fourth quarter.

    • Alexandria Real Estate (NYSE:ARE) is likely to report earnings for its fourth quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AEVA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEVA
    $AGS
    $AGTI
    $ALNT

    CompanyDatePrice TargetRatingAnalyst
    Cipher Mining Inc.
    $CIFR
    2/9/2026$38.00Overweight
    Morgan Stanley
    Dave Inc.
    $DAVE
    2/9/2026Outperform
    Keefe Bruyette
    Park-Ohio Holdings Corp.
    $PKOH
    2/9/2026$37.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Fabrinet
    $FN
    2/4/2026$540.00Peer Perform → Outperform
    Wolfe Research
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    Alexandria Real Estate Equities Inc.
    $ARE
    2/3/2026$60.00Neutral
    Goldman
    Orthofix Medical Inc.
    $OFIX
    1/27/2026$14.00Hold
    TD Cowen
    Target Corporation
    $TGT
    1/27/2026Underperform → Peer Perform
    Wolfe Research
    More analyst ratings

    $AEVA
    $AGS
    $AGTI
    $ALNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Keefe Bruyette initiated coverage on Dave, Inc.

    Keefe Bruyette initiated coverage of Dave, Inc. with a rating of Outperform

    2/9/26 7:01:11 AM ET
    $DAVE
    Finance: Consumer Services
    Finance

    Morgan Stanley initiated coverage on Cipher Mining with a new price target

    Morgan Stanley initiated coverage of Cipher Mining with a rating of Overweight and set a new price target of $38.00

    2/9/26 7:01:11 AM ET
    $CIFR
    Finance: Consumer Services
    Finance

    Park-Ohio upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Park-Ohio from Sector Weight to Overweight and set a new price target of $37.00

    2/9/26 6:58:22 AM ET
    $PKOH
    Industrial Specialties
    Industrials

    $AEVA
    $AGS
    $AGTI
    $ALNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Operating Officer Gaylor Douglas Walter

    4 - Crexendo, Inc. (0001075736) (Issuer)

    2/6/26 5:31:34 PM ET
    $CXDO
    Telecommunications Equipment
    Telecommunications

    SEC Form 4 filed by Chief Executive Officer Korn Jeffrey G

    4 - Crexendo, Inc. (0001075736) (Issuer)

    2/6/26 5:24:15 PM ET
    $CXDO
    Telecommunications Equipment
    Telecommunications

    SEC Form 4 filed by Chief Financial Officer Vincent Ron

    4 - Crexendo, Inc. (0001075736) (Issuer)

    2/6/26 5:17:31 PM ET
    $CXDO
    Telecommunications Equipment
    Telecommunications

    $AEVA
    $AGS
    $AGTI
    $ALNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fox Factory Announces Strategic Board Refresh

    Company to Appoint Two New Independent Directors and Form Transformation Committee Focused on Operational Excellence and Margin Improvement Company Enters into Cooperation Agreement with Engine Capital DULUTH, Ga., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (Nasdaq: FOXF) ("Fox Factory" or the "Company"), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers worldwide, today announced that following constructive discussions with Engine Capital ("Engine Capital") regarding opportunities to enhance operational performance and profitability, the Company will be undertaking a strategic boar

    2/9/26 4:05:00 PM ET
    $FOXF
    $OFIX
    Motor Vehicles
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Cipher Mining Announces Date of Fourth Quarter and Full Year 2025 Business Update Conference Call

    NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) ("Cipher" or the "Company") today announced it will provide a business update and release its fourth quarter and full year 2025 financial results before U.S. markets open on Tuesday, February 24th, 2026. Cipher will host a conference call and webcast that day at 8:00 a.m. Eastern Time. The live webcast and a webcast replay of the conference call can be accessed from the investor relations section of Cipher's website at https://investors.ciphermining.com. About CipherCipher is focused on the development and operation of industrial-scale data centers for bitcoin mining and HPC hosting. Cipher aims to be a market l

    2/9/26 4:05:00 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

    SAN DIEGO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced Bionano Symposium 2026, the premier global event for the optical genome mapping (OGM) community. This virtual symposium provides a unique platform for researchers to present cutting-edge findings and share insights into emerging applications of OGM technology. Join leading scientists from around the world as they highlight breakthroughs in OGM from February 23-26, 2026. The four-day event will feature presentations from over 30 researchers across North America, Europe, and Asia, covering research applications in hematologic malignancies, solid tumors, bioprocessing, constitutional genetic dis

    2/9/26 9:05:00 AM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AEVA
    $AGS
    $AGTI
    $ALNT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Fitzgerald John Taylor Maloney bought $2,505 worth of shares (183 units at $13.69), increasing direct ownership by 0.01% to 1,460,086 units (SEC Form 4)

    4 - KINGSWAY FINANCIAL SERVICES INC (0001072627) (Issuer)

    2/2/26 6:45:17 PM ET
    $KFS
    Property-Casualty Insurers
    Finance

    CFO & EVP Hansen Kent A bought $1,561 worth of shares (114 units at $13.69), increasing direct ownership by 0.10% to 119,707 units (SEC Form 4)

    4 - KINGSWAY FINANCIAL SERVICES INC (0001072627) (Issuer)

    2/2/26 6:41:30 PM ET
    $KFS
    Property-Casualty Insurers
    Finance

    President and CEO Fitzgerald John Taylor Maloney bought $2,505 worth of shares (185 units at $13.54), increasing direct ownership by 0.01% to 1,459,903 units (SEC Form 4)

    4 - KINGSWAY FINANCIAL SERVICES INC (0001072627) (Issuer)

    1/29/26 6:39:07 PM ET
    $KFS
    Property-Casualty Insurers
    Finance

    $AEVA
    $AGS
    $AGTI
    $ALNT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    April 26, 2023 - FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection

    For Immediate Release: April 26, 2023 Today, the U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally. Vowst is approved for the prevention of recurrence of Clostridioides difficile (C. difficile) infection (CDI) in individuals 18 years of age and older, following antibacterial treatment for recurrent CDI.  “Today’s approval provides patients and healthcare p

    4/26/23 6:04:21 PM ET
    $MCRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEVA
    $AGS
    $AGTI
    $ALNT
    SEC Filings

    View All

    SEC Form 424B3 filed by Nuwellis Inc.

    424B3 - Nuwellis, Inc. (0001506492) (Filer)

    2/9/26 5:22:12 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SCHEDULE 13G filed by Cumberland Pharmaceuticals Inc.

    SCHEDULE 13G - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Subject)

    2/9/26 5:12:05 PM ET
    $CPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Rigel Pharmaceuticals Inc.

    SCHEDULE 13G - RIGEL PHARMACEUTICALS INC (0001034842) (Subject)

    2/9/26 8:02:28 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEVA
    $AGS
    $AGTI
    $ALNT
    Financials

    Live finance-specific insights

    View All

    Cipher Mining Announces Date of Fourth Quarter and Full Year 2025 Business Update Conference Call

    NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) ("Cipher" or the "Company") today announced it will provide a business update and release its fourth quarter and full year 2025 financial results before U.S. markets open on Tuesday, February 24th, 2026. Cipher will host a conference call and webcast that day at 8:00 a.m. Eastern Time. The live webcast and a webcast replay of the conference call can be accessed from the investor relations section of Cipher's website at https://investors.ciphermining.com. About CipherCipher is focused on the development and operation of industrial-scale data centers for bitcoin mining and HPC hosting. Cipher aims to be a market l

    2/9/26 4:05:00 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    Aeva Announces Date for Fourth Quarter and Full Year 2025 Results and Conference Call

    Aeva® (NASDAQ:AEVA), a leader in next-generation sensing and perception systems, today announced it will report results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026. Aeva will host a conference call and webcast to discuss the fourth quarter and full year 2025 results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. Event: Aeva Technologies, Inc. Fourth Quarter and Full Year 2025 Results Call Date: Thursday, February 26, 2026 Time: 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Join by webcast: investors.aeva.com An archive of the webcast will be available shortly after the call on our investor relations website inv

    2/9/26 7:00:00 AM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    Dave Reports Preliminary Fourth Quarter and Full Year 2025 Results

    2025 Revenue and Adjusted EBITDA Results are Expected to Exceed the Top-End of Guidance 4Q25 28 DPD Rate Expected to be Within the Range of 1.95%-2.00%, Outperforming Guidance of Below 2.10% Full Earnings Results and 2026 Financial Outlook to Be Discussed on March 2, 2026 at 5:00pm ET LOS ANGELES, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced certain preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The Company expects to release full, audited financial results and file its annual report on Form 10-K for the year ended December 31, 2025 on Mar

    2/5/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    $AEVA
    $AGS
    $AGTI
    $ALNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Neuronetics Inc.

    SC 13D - Neuronetics, Inc. (0001227636) (Subject)

    12/17/24 9:15:11 PM ET
    $STIM
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by Myers Industries Inc.

    SC 13D/A - MYERS INDUSTRIES INC (0000069488) (Subject)

    12/13/24 4:12:08 PM ET
    $MYE
    Plastic Products
    Industrials

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AEVA
    $AGS
    $AGTI
    $ALNT
    Leadership Updates

    Live Leadership Updates

    View All

    Fox Factory Announces Strategic Board Refresh

    Company to Appoint Two New Independent Directors and Form Transformation Committee Focused on Operational Excellence and Margin Improvement Company Enters into Cooperation Agreement with Engine Capital DULUTH, Ga., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (Nasdaq: FOXF) ("Fox Factory" or the "Company"), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers worldwide, today announced that following constructive discussions with Engine Capital ("Engine Capital") regarding opportunities to enhance operational performance and profitability, the Company will be undertaking a strategic boar

    2/9/26 4:05:00 PM ET
    $FOXF
    $OFIX
    Motor Vehicles
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care